Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrimson Tide Regulatory News (TIDE)

Share Price Information for Crimson Tide (TIDE)

Share Price is delayed by 15 minutes
Get Live Data
92.50    5.00 (5.71%)
Bid:
90.00
Ask:
95.00
Spread: 5.00 (5.556%)
Market Cap: £6.08m
TIDE Live PriceLast checked at - London Stock Exchange

Intraday Crimson Tide Share Chart

Customer Contracts Update

24 Dec 2025 07:00

RNS Number : 7312M
Crimson Tide PLC
24 December 2025
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION NO. 596/2014 (AS INCORPORATED INTO UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 AS AMENDED BY VIRTUE OF THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS 2019). UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN

 

24 December 2025

Crimson Tide plc

("Crimson Tide", the "Company" or the "Group")

Customer Contracts Update

Crimson Tide plc (AIM:TIDE), the provider of the mpro5 process management app, announces that it has received formal notice from a significant customer, a major retailer (the "Customer"), that it intends to exercise a break clause in its existing contract with the Company. The break clause will take effect on 31 March 2026. To note, this does not relate to the contract renewal which was announced on 10 November 2025.

The Company remains in constructive dialogue with the Customer regarding transition arrangements and is implementing mitigation strategies to reduce the impact of this change.

 

Whilst the Company is disappointed to lose a valued customer, this change will release considerable resources previously dedicated to servicing this account. The Customer's requirements necessitated significant bespoke development within the platform, which has constrained product development capacity. The conclusion of this contract will enable the Company to redeploy resources towards higher-margin opportunities, accelerate delivery of core product enhancements and support the Company's strategy to build a more scalable SaaS platform. Whilst there will be an immediate impact on revenue, the Board believes that this transition will benefit the Company over the longer term.

 

The contract, which commenced on 1 December 2024, represented approximately 12% of the Company's annual recurring revenue ("ARR") for the financial year ended 30 April 2025 and 30 April 2026, albeit at below average margins for the reasons explained above.

 

The Company has separately secured renewal agreements with two customers, representing combined monthly recurring revenue ("MRR") of approximately £14,700 for 12 months. Both customers had previously served notice of non-renewal and were therefore classified as churned. Following a renewed focus by the current management team on customer retention, and the implementation of a structured retention strategy focused on maximising customer value from mpro5, the Company has successfully re-engaged and retained both customers.

 

Enquiries:

 

Crimson Tide plc

+ 44 1892 542444

Chris Fielding, Non-Executive Chair

Jon Clarke, Chief Executive Officer

Rachael Rowe, Finance Director

Allenby Capital Limited - Nominated Adviser & Broker

+44 (0)20 3328 5656

Jeremy Porter / Ashur Joseph (Corporate Finance)

info@allenbycapital.com

Tony Quirke / Lauren Wright (Sales & Corporate Broking)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDPKNBNFBDDCBB
Date   Source Headline
9th Jun 20267:00 amRNS-RNew contract trials: Sim Trava and DW Baking
5th Jun 202612:26 pmRNSHolding(s) in Company
5th May 20267:00 amRNSYear End Trading Update
24th Apr 20267:00 amRNSAIM Director Disclosure Update
2nd Apr 20267:00 amRNS-RNew Contract Wins
9th Mar 202610:00 amRNSConcert Party Update
26th Feb 20267:00 amRNSNon-Executive Director Appointments
18th Feb 20267:00 amRNS-RRenewal of Contract
23rd Jan 20267:00 amRNSChange of Non-Executive Director
29th Dec 20259:21 amRNSHolding(s) in Company
24th Dec 20257:00 amRNSCustomer Contracts Update
4th Dec 20255:43 pmRNSHolding(s) in Company
27th Nov 20257:00 amRNSDirector/PDMR Shareholding - Grant of Options
19th Nov 20257:00 amRNSInterim Results
10th Nov 20253:14 pmRNSContract Renewal with Major Global Retailer
3rd Nov 20254:20 pmRNSHolding(s) in Company
31st Oct 20252:46 pmRNSResult of AGM
31st Oct 20259:28 amRNSHolding(s) in Company
31st Oct 20257:00 amRNSHolding(s) in Company
31st Oct 20257:00 amRNSAGM Statement
27th Oct 20254:45 pmRNSHolding(s) in Company
27th Oct 20254:43 pmRNSHolding(s) in Company
6th Oct 20257:00 amRNSAudited Full Year Results
29th Sep 20257:00 amRNSUpdate on Audited Results
22nd Jul 20257:00 amRNSAppointment of Chief Executive Officer
14th Jul 20252:40 pmRNSHolding(s) in Company
7th Jul 20257:00 amRNSContract Renewal with Major UK Wholesaler
4th Jul 20257:00 amRNSAppointment of Finance Director
12th Jun 202510:46 amRNSHolding(s) in Company
5th Jun 20257:00 amRNSAppointment of Chair, Nominated Adviser and Broker
30th May 20257:00 amRNSSecond Interim Results
29th May 20257:00 amRNSContract Renewal with Major British Supermarket
6th May 20257:00 amRNSChange of Accounting Reference Date
15th Apr 20253:58 pmRNSBoard Appointment
26th Mar 202511:00 amRNSBoard Changes
20th Mar 20252:29 pmRNSBoard Change
20th Mar 202512:36 pmRNSForm 8.5 (EPT/RI) - Amendment
20th Mar 202510:25 amRNSForm 8.5 (EPT/RI)
19th Mar 202511:50 amRNSResults of Court Meeting and General Meeting
18th Mar 20259:35 amRNSForm 8.5 (EPT/NON-RI)
17th Mar 20253:06 pmGNWForm 8.3 - Crimson Tide Plc
17th Mar 202512:00 pmRNSForm 8.5 (EPT/RI)
14th Mar 20253:05 pmGNWForm 8.3 - Crimson Tide Plc
14th Mar 202511:58 amRNSForm 8.5 (EPT/RI)
12th Mar 202512:05 pmRNSForm 8.5 (EPT/RI)
12th Mar 20259:23 amRNSForm 8.5 (EPT/NON-RI)
11th Mar 202510:32 amRNSForm 8.5 (EPT/RI)
11th Mar 20257:00 amRNSOffer Update
10th Mar 202512:01 pmRNSForm 8.5 (EPT/RI)
7th Mar 202512:23 pmRNSForm 8.3 - Crimson Tide plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.